FDA Cleared
New Device
Pathway: 510K
eplex RP3 Control M530; eplex RP3 Negative
Applicant:
Maine Molecular Quality Controls, Inc.
Statutory Profile
Legal Standard:
Substantial Equivalence (SE) to predicate (21 CFR 807)
Product Code:
PMN
Review Panel:
Microbiology
21 CFR Regulation:
8
Review Velocity Metrics
Date Received:
2026-09-16
Decision Date:
2026-10-30
Total Review Duration:
44 calendar days (44 days)
Official FDA Research Backlinks
Direct links to primary official records hosted by the U.S. Food and Drug Administration CDRH databases:
Identified Contacts & Correspondents
Joan Gordon
Role: SUBMITTER_CONTACT
Notice a discrepancy or outdated information on this record?
Report to support@fdacleared.org